Cancer Research Cancer Health Disparities Conference 2009  Cancer Genome no Abstract
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nisato, R. E.
Right arrow Articles by Pepper, M. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nisato, R. E.
Right arrow Articles by Pepper, M. S.
[Cancer Research 65, 9377-9387, October 15, 2005]
© 2005 American Association for Cancer Research


Cell and Tumor Biology

Dissecting the Role of Matrix Metalloproteinases (MMP) and Integrin {alpha}vß3 in Angiogenesis In vitro: Absence of Hemopexin C Domain Bioactivity, but Membrane-Type 1-MMP and {alpha}vß3 Are Critical

Riccardo E. Nisato1, Ghamartaj Hosseini1, Christian Sirrenberg2, Georgina S. Butler4, Thomas Crabbe5, Andrew J.P. Docherty5, Matthias Wiesner3, Gillian Murphy6, Christopher M. Overall4, Simon L. Goodman2 and Michael S. Pepper1,7

1 Department of Morphology, University Medical Center, Geneva, Switzerland; 2 Oncology Research and 3 Medicinal Chemistry, Merck KGaA, Darmstadt, Germany; 4 Centre for Blood Research, Department of Oral Biological and Medical Sciences, and Department of Biochemistry and Molecular Biology, University of British Columbia, Vancouver, British Columbia, Canada; 5 Celltech, Slough, Berkshire, United Kingdom; 6 School of Biological Sciences, University of East Anglia, Norwich, United Kingdom; and 7 NetCare Molecular Medicine Institute, Unitas Hospital, and Department of Immunology, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa

Requests for reprints: Michael S. Pepper, NetCare Molecular Medicine Institute, Unitas Hospital, Clifton Avenue, 0140 Lyttleton, Pretoria, South Africa. Phone: 27-12-677-8504; Fax: 27-12-677-8505; E-mail: mpepper{at}doctors.netcare.co.za.

Matrix metalloproteinase (MMP)-2 and its hemopexin C domain autolytic fragment (also called PEX) have been proposed to be crucial for angiogenesis. Here, we have investigated the dependency of in vitro angiogenesis on MMP-mediated extracellular proteolysis and integrin {alpha}vß3–mediated cell adhesion in a three-dimensional collagen I model. The hydroxamate-based synthetic inhibitors BB94, CT1399, and CT1847 inhibited endothelial cell invasion, as did neutralizing anti–membrane-type 1-MMP (MT1-MMP) antibodies and tissue inhibitor of MMP (TIMP)-2 and TIMP-3 but not TIMP-1. This confirmed the pivotal importance of MT1-MMP over other MMPs in this model. Invasion was also inhibited by a nonpeptidic antagonist of integrin {alpha}vß3, EMD 361276. Although PEX strongly inhibited pro-MMP-2 activation, when contaminating lipopolysaccharide was neutralized, PEX neither affected angiogenesis nor bound integrin {alpha}vß3. Moreover, no specific binding of pro-MMP-2 to integrin {alpha}vß3 was found, whereas only one out of four independently prepared enzymatically active MMP-2 preparations could bind integrin {alpha}vß3, and this in a PEX-independent manner. Likewise, integrin {alpha}vß3–expressing cells did not bind MMP-2-coated surfaces. Hence, these findings show that endothelial cell invasion of collagen I gels is MT1-MMP and {alpha}vß3- dependent but MMP-2 independent and does not support a role for PEX in {alpha}vß3 integrin binding or in modulating angiogenesis in this system.




This article has been cited by other articles:


Home page
Mol. Biol. CellHome page
P. A. Rupp, R. P. Visconti, A. Czirok, D. A. Cheresh, and C. D. Little
Matrix Metalloproteinase 2-Integrin {alpha}v{beta}3 Binding Is Required for Mesenchymal Cell Invasive Activity but Not Epithelial Locomotion: A Computational Time-Lapse Study
Mol. Biol. Cell, December 1, 2008; 19(12): 5529 - 5540.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
H. Kang, K. J. Bayless, and R. Kaunas
Fluid shear stress modulates endothelial cell invasion into three-dimensional collagen matrices
Am J Physiol Heart Circ Physiol, November 1, 2008; 295(5): H2087 - H2097.
[Abstract] [Full Text] [PDF]


Home page
INT J LOW EXTREM WOUNDSHome page
M. S. Agren and M. Werthen
The Extracellular Matrix in Wound Healing: A Closer Look at Therapeutics for Chronic Wounds
International Journal of Lower Extremity Wounds, June 1, 2007; 6(2): 82 - 97.
[Abstract] [PDF]


Home page
J. Leukoc. Biol.Home page
H. Piccard, P. E. Van den Steen, and G. Opdenakker
Hemopexin domains as multifunctional liganding modules in matrix metalloproteinases and other proteins
J. Leukoc. Biol., April 1, 2007; 81(4): 870 - 892.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. J. Morrison and C. M. Overall
TIMP Independence of Matrix Metalloproteinase (MMP)-2 Activation by Membrane Type 2 (MT2)-MMP Is Determined by Contributions of Both the MT2-MMP Catalytic and Hemopexin C Domains
J. Biol. Chem., September 8, 2006; 281(36): 26528 - 26539.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2005 by the American Association for Cancer Research.